Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04962477 · ClinicalTrials.gov registry record
Understanding Host-pathogen Interaction in the Respiratory Mucosa During Pregnancy
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 48
- Enrollment target
NCT04962477: Completed study, sponsored by Washington University School of Medicine.
NCT04962477 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04962477 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
The clinical presentation of the ongoing coronavirus disease-19 (COVID-19) pandemic in pregnant women is unique with more asymptomatic infection, higher morbidity when symptomatic, yet without a difference in mortality rate. This is strikingly different from the high mortality observed during the past influenza A pandemics. Though both influenza A virus (IAV) and SARS-CoV-2 are single-stranded RNA viruses, the exquisite vulnerability of pregnant women to influenza A but not COVID-19 remains a mystery. Our objective, therefore, is to determine the mechanisms that predispose pregnant women to severe influenza A but confer protection against SARS-CoV-2 infection by examining the viral entry factors and innate immune response mechanisms in the nasal epithelium of pregnant vs. non-pregnant age-matched women.
Interventions
- OTHER Nasal brush sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2023-09-27 |
What the finished NCT04962477 record still lists
NCT04962477 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Nasal brush sampling is the first listed.
NCT04962477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04962477 about?
NCT04962477 is a clinical study titled "Understanding Host-pathogen Interaction in the Respiratory Mucosa During Pregnancy". The clinical presentation of the ongoing coronavirus disease-19 (COVID-19) pandemic in pregnant women is unique with more asymptomatic infection, higher morbidity when symptomatic, yet without a difference in mortality rate. This is strikingly different from the high mortality observed during the pa...
What is the current status of trial NCT04962477?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2022-03-02. Estimated completion is 2023-09-27.
What interventions are being tested in trial NCT04962477?
The interventions under investigation include: Nasal brush sampling (OTHER).
Who is sponsoring clinical trial NCT04962477?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI